Cost‐effectiveness of precision diagnostic testing for precision medicine approaches against non‐small‐cell lung cancer: A systematic review

Precision diagnostic testing (PDT) employs appropriate biomarkers to identify cancer patients that may optimally respond to precision medicine (PM) approaches, such as treatments with targeted agents and immuno‐oncology drugs. To date, there are no published systematic appraisals evaluating the cost...

Descripción completa

Detalles Bibliográficos
Autores principales: Henderson, Raymond, Keeling, Peter, French, Declan, Smart, Dave, Sullivan, Richard, Lawler, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486593/
https://www.ncbi.nlm.nih.gov/pubmed/34110679
http://dx.doi.org/10.1002/1878-0261.13038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486593/
https://www.ncbi.nlm.nih.gov/pubmed/34110679
http://dx.doi.org/10.1002/1878-0261.13038

Ejemplares similares